Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Min Dong

University of Macau, China

Title: Concurrent antipsychotic use in older adults treated with antidepressants in Asia”

Biography

Biography: Min Dong

Abstract

Statement of the Problem: Depressive disorders are common in old age. The prevalence of major depressive disorder, minor depression and clinically relevant depressive symptoms in old people living in the community were 1.8%, 9.8% and 13.5%, respectively. Compared to younger adults, older adults suffering from depression have an increased risk of physical and psychological comorbidities, more disability and social isolation, greater economic cost, and higher mortality. Psychotropic medications are prescribed for old people up to 7-18 times more frequently than for middle-aged adults. Antipsychotics (APs) are often used as an adjunctive treatment with antidepressants (ADs) in this population but its patterns of use in Asia are not known. This study explored the rate of combination

of APs and ADs in older adult psychiatric patients in Asia.

Methodology: This is a secondary analysis of the database of a multicenter study which recorded participants’ basic demographical and clinical data in standardized format in ten Asian countries and territories. The data were analyzed using univariate and multivariate logistic regression analyses.

Findings: A total of 955 older adult psychiatric in and outpatients were included in this study. The proportion of concurrent AP and AD use was 32.0%, ranging from 23.3% in Korea to 44.0% in Taiwan. Multivariate logistic regression analysis found that younger age, inpatient status and diagnosis of schizophrenia were significantly related to a higher proportion of concurrent use of APs and ADs.

Conclusion: Around a third of older adult psychiatric patients had concurrent AP and AD use in the Asian countries / regions surveyed. Considering the uncertain effectiveness and questionable safety of the APs and ADs combination in this patient population, this type of polypharmacy should be used cautiously.

 

Recent Publications

1. Harper C (2009) The neuropathology of alcohol-related brain damage. Alcohol 44: 136-140.

2. Heilig M and Egli M (2006) Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharmacology and Therapeutics 111: 855-876.

3. Li X, Schwacha M G, Chaudry I H and Choudhry M A (2008) Acute alcohol intoxication potentiates neutrophilmediated intestinal tissue damage after burn injury. Shock 29(3): 377-383.

4. Room R, Babor T and Rehm J (2005) Alcohol and public health. Lancet 365: 519-530.

5. Sullivan E V and Zahr N M (2008) Neuroinflammation as a neurotoxic mechanism in alcoholism: Commentary on “Increased MCP-1 and microglia in various regions of human alcoholic brain”. Experimental neurology 213(1):10-17.